Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion type Assertion NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_head.
- NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion description "[Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_provenance.
- NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion evidence source_evidence_curated NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_provenance.
- NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion SIO_000772 17565644 NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_provenance.
- NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion wasDerivedFrom ctd_human-2016 NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_provenance.
- NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion wasGeneratedBy ECO_0000218 NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_provenance.